Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Revenue

In the year 2024, Arcutis Biotherapeutics had annual revenue of $196.54M with 229.74% growth. Arcutis Biotherapeutics had revenue of $71.36M in the quarter ending December 31, 2024, with 427.58% growth.

• Revenue (ttm): $196.54M
• Revenue Growth: +229.74%
• P/S Ratio: 9.68
• Revenue / Employee: $574,684
• Employees: 342
• Market Cap: 1.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	196.54M	136.94M	229.74%
Dec 31, 2023	59.61M	55.92M	1,517.09%
Dec 31, 2022	3.69M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.